Wrapping up Q4 earnings, we look at the numbers and key takeaways for the personal care stocks, including Herbalife (NYSE: HLF) and its peers.

While personal care products products may seem more discretionary than food, consumers tend to maintain or even boost their spending on the category during tough times. This phenomenon is known as "the lipstick effect" by economists, which states that consumers still want some semblance of affordable luxuries like beauty and wellness when the economy is sputtering. Consumer tastes are constantly changing, and personal care companies are currently responding to the public’s increased desire for ethically produced goods by featuring natural ingredients in their products.

The 12 personal care stocks we track reported a mixed Q4. As a group, revenues beat analysts’ consensus estimates by 1.3% while next quarter’s revenue guidance was 1.2% above.

Amidst this news, share prices of the companies have had a rough stretch. On average, they are down 9.8% since the latest earnings results.

Herbalife (NYSE: HLF)

With the first products sold out of the trunk of the founder’s car, Herbalife (NYSE: HLF) today offers a portfolio of shakes, supplements, personal care products, and weight management programs to help customers reach their nutritional and fitness goals.

Herbalife reported revenues of $1.28 billion, up 6.3% year on year. This print exceeded analysts’ expectations by 3.6%. Overall, it was a satisfactory quarter for the company with an impressive beat of analysts’ gross margin estimates but a significant miss of analysts’ EPS estimates.

“We exited 2025 with solid momentum, delivering Q4 and full‑year net sales growth and adjusted EBITDA1 above guidance. Cristiano Ronaldo’s investment in Pro2col reflects our shared ambition to scale personalized nutrition and wellness globally—uniting science, data, AI, innovation, and community to improve the health and performance of millions.”

Unsurprisingly, the stock is down 4.3% since reporting and currently trades at $15.83.

Is now the time to buy Herbalife? Access our full analysis of the earnings results here, it’s free.

Best Q4: e.l.f. Beauty (NYSE: ELF)

Short for "eyes, lips, face", e.l.f. Beauty (NYSE: ELF) is a developer of high-quality beauty products at accessible price points.

e.l.f. Beauty reported revenues of $489.5 million, up 37.8% year on year, outperforming analysts’ expectations by 6.4%. The business had a stunning quarter with a beat of analysts’ EPS estimates and a solid beat of analysts’ EBITDA estimates.

e.l.f. Beauty scored the biggest analyst estimates beat and fastest revenue growth among its peers. Although it had a fine quarter compared its peers, the market seems unhappy with the results as the stock is down 11.6% since reporting. It currently trades at $74.85.

Is now the time to buy e.l.f. Beauty? Access our full analysis of the earnings results here, it’s free.

Weakest Q4: Medifast (NYSE: MED)

Known for its Optavia program that combines portion-controlled meal replacements with coaching, Medifast (NYSE: MED) has a broad product portfolio of bars, snacks, drinks, and desserts for those looking to lose weight or consume healthier foods.

Medifast reported revenues of $75.1 million, down 36.9% year on year, exceeding analysts’ expectations by 5.2%. Still, it was a softer quarter as it posted full-year revenue guidance missing analysts’ expectations significantly and full-year EPS guidance missing analysts’ expectations significantly.

Medifast delivered the highest full-year guidance raise but had the slowest revenue growth in the group. As expected, the stock is down 7% since the results and currently trades at $10.05.

Read our full analysis of Medifast’s results here.

Estée Lauder (NYSE: EL)

Named after its founder, who was an entrepreneurial woman from New York with a passion for skincare, Estée Lauder (NYSE: EL) is a one-stop beauty shop with products in skincare, fragrance, makeup, sun protection, and men’s grooming.

Estée Lauder reported revenues of $4.23 billion, up 5.6% year on year. This number met analysts’ expectations. It was a strong quarter as it also logged an impressive beat of analysts’ EBITDA estimates and a decent beat of analysts’ adjusted operating income estimates.

The stock is down 26.1% since reporting and currently trades at $88.44.

Read our full, actionable report on Estée Lauder here, it’s free.

Olaplex (NASDAQ: OLPX)

Rising to fame on TikTok because of its “bond building" hair products, Olaplex (NASDAQ: OLPX) offers products and treatments that repair the damage caused by traditional heat and chemical-based styling goods.

Olaplex reported revenues of $105.1 million, up 4.3% year on year. This result surpassed analysts’ expectations by 1.1%. Overall, it was a very strong quarter as it also recorded a solid beat of analysts’ EBITDA estimates and an impressive beat of analysts’ adjusted operating income estimates.

The stock is down 30.1% since reporting and currently trades at $1.25.

Read our full, actionable report on Olaplex here, it’s free.

Want to invest in winners with rock-solid fundamentals? Check out our Top 5 Growth Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate.